HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Blockade of morphine-induced behavioral sensitization by a combination of amisulpride and RB101, comparison with classical opioid maintenance treatments.

AbstractBACKGROUND AND PURPOSE:
Maintenance treatments with methadone or buprenorphine are more or less efficient procedures for helping heroin addicts to stop or reduce drug abuse. Another approach to treat opiate dependence could be to target the endogenous opioid system by enhancing the effects of enkephalins by protecting them from enzymic degradation by the dual peptidase inhibitor RB101.
EXPERIMENTAL APPROACH:
As chronic treatment with the dopamine D2 antagonist amisulpride facilitates RB101-induced behavioral effects, we chose in this study to treat mice previously sensitized to the hyperlocomotor effects induced by morphine with a combination of amisulpride and RB101.
KEY RESULTS:
Expression of morphine-induced locomotor sensitization was abolished after combined treatment with amisulpride (20 mg x kg(-1), i.p.) and RB101 (80 mg x kg(-1), i.p.), whereas these drugs were not effective when used alone. We then compared these results with the effects of amisulpride combined with buprenorphine (0.1 mg x kg(-1), i.p.) or methadone (2.5 mg x kg(-1), i.p.) upon morphine-induced behavioral sensitization. Whereas the combination of amisulpride and buprenorphine partially blocked the expression of morphine sensitization, amisulpride+methadone was not effective in this paradigm.
CONCLUSIONS AND IMPLICATIONS:
The combination of amisulpride+RB101 appears to be very efficient in blocking the expression of morphine-induced behavioral sensitization. This could reflect a reinstatement of a balance between the function of the dopamine and opioid systems and could represent a new approach in maintenance treatments for opiate addiction.
AuthorsL Cordonnier, M Sanchez, B P Roques, F Noble
JournalBritish journal of pharmacology (Br J Pharmacol) Vol. 151 Issue 1 Pg. 94-102 (May 2007) ISSN: 0007-1188 [Print] England
PMID17351659 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Disulfides
  • RB 101
  • Buprenorphine
  • Phenylalanine
  • Morphine
  • Sulpiride
  • Amisulpride
  • Methadone
Topics
  • Amisulpride
  • Animals
  • Behavior, Animal (drug effects)
  • Buprenorphine (pharmacology)
  • Disulfides (pharmacology)
  • Male
  • Methadone (pharmacology)
  • Mice
  • Morphine (antagonists & inhibitors)
  • Motor Activity (drug effects)
  • Opioid-Related Disorders (drug therapy)
  • Phenylalanine (analogs & derivatives, pharmacology)
  • Sulpiride (analogs & derivatives, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: